Pharmacy
Who profits from Obamacare..Guess! The Secret Power Elite
The Phamaceutical Companies Big List of Drug Induced Killers
As WND has reported, Charleston church shooter Dylann Roof was a known drug user who was caught with the powerful mind-altering narcotic Suboxone when apprehended by police during an incident on Feb. 28. Suboxone is used to treat addiction to opioid drugs such as heroin. It’s adverse effects include anxiety, irritability, depersonalization, confusion, suicidal thoughts and irrational, sometimes violent behavior.
Other drugs linked to mass killers have more often been geared toward treating mental illness. According to a data set of U.S. mass shootings from 1982-2012 prepared by Mother Jones magazine, of 62 mass shootings carried out by 64 shooters, the majority of the shooters (41) were noted to have signs of possible mental illness — the precise kinds of mental illnesses that psychotropic medications are prescribed for...MORE
Big Pharma wants to run medical experiments on your babies
****************
Obamacare Illustrated..A picture is worth a thousand words, and, Lord knows, we’ve written thousands – actually, hundreds of thousands – of words about ObamaCare. So on this third anniversary of the passage of this destructive law, we have put together links to resources to help explain the bureaucratic scale of ObamaCare in another way.
List of Aborted Baby Products and Contaminated Vaccines
Our children and unborn babies are being used as commodities and soon will be traded like livestock. A California company is using organs from aborted babies to grow full sized organs for transplants. Google is on a quest for immortality. Will they turn to this sickening procedure in their quests to become gods on earth? https://www.bloomberg.com/news/articles/2015-03-09/google-ventures-bill-maris-investing-in-idea-of-living-to-500
https://www.wnd.com/2015/03/aborted-baby-organ-program-called-frankenscience/
Aborted baby organs to be used to grow transplants for medical patients
Pharmaceutical Giant GlaxoSmithKline 'Accidentally' Released 45 Liters of Concentrated Live Polio Virus in the Environment
by Global Research News
[Belgium] As reported to ECDC by Belgian authorities, on 2 September 2014, following a human error, 45 litres of concentrated live polio virus solution were released into the environment by the pharmaceutical company, GlaxoSmithKline (GSK), in Rixensart city, Belgium. The liquid was conducted directly to a water-treatment plant (Rosieres) and released after treatment in river Lasne affluent of river Dyle which is affluent of the Escaut/Scheldt river. Belgium's High Council of Public Health conducted a risk assessment that concluded that the risk of infection for the population exposed to the contaminated water is extremely low due to the high level of dilution and the high vaccination coverage (95%) in Belgium.
ECDC's assessment is that the accidental release in the environment of large amounts of live polio virus represents a risk to public health if susceptible populations, such as areas with low polio vaccine coverage, are exposed to contaminated waters or mud. Particularly since the Lasne and Dyle rivers are joining the Escaut/Scheldt river which flows in the southwestern part of the Netherlands where various orthodox protestant communities present a lower polio vaccination coverage, before reaching the North Sea...MORE
What the Top 10 Biopharma [Obamacare] CEOs Are Making
by Alex Philippidis
These biotech leaders are the ones bringing home the most bacon:
#10. Merck & Co.
Kenneth C. Frazier, Chairman, President, and CEO
2011 Compensation: $13,347,652
2010 Compensation: $9,439,632
% Change: 41.1%
#9. Baxter International
Robert L. Parkinson Jr., Chairman and CEO
2011 Compensation: $14,065,479
2010 Compensation: $11,500,268
% Change: 22.3%
#8. Bristol-Myers Squibb
Lamberto Andreotti, CEO
2011 Compensation: $14,911,947
2010 Compensation: $11,770,880
% Change: 26.7%
#7. Gilead Sciences
John C. Martin, Chairman and CEO
2011 Compensation: $15,615,645
2010 Compensation: $14,244,388
% Change: 9.6%
#6. Novartis
Joseph Jimenez, CEO
2011 Compensation1: $15,881,621
2010 Compensation1: $11,828,828
% Change: 34.3%
#5. Eli Lilly
John C. Lechleiter, Ph.D., Chairman, President, and CEO
2011 Compensation: $16,370,094
2010 Compensation: $16,504,545
% Change: -0.8%
#4. Amgen
Kevin W. Sharer, Chairman and CEO
2011 Compensation: $18,850,311
2010 Compensation: $21,138,133
% Change: -10.8%
#3. Abbott
Miles D. White, Chairman, CEO, and Director
2011 Compensation: $24,010,902
2010 Compensation: $25,564,283
% Change: -6.1%
#2. Pfizer
Ian Read, Chairman and CEO
2011 Compensation: $25,013,348
2010 Compensation: $17,396,112
% Change: 43.8%
#1. Johnson & Johnson
William C. Weldon, Chairman/CEO
2011 Compensation: $26,797,939
2010 Compensation: $28,720,491
% Change: -6.7%
1Converted to USD from CHF. [[Swiss franks]] Total compensation includes salary, bonuses if any, stock awards, option awards, non-equity incentive plan compensation, annual charge to the pension fund plus non-qualified deferred compensation earnings, and all other forms of compensation. Figures were obtained from proxy statements and annual reports.
